FDA Inspection 817164 — Mary Bird Perkins Cancer Center
The FDA completed an inspection of Mary Bird Perkins Cancer Center on February 5, 2013 in Houma, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 5, 2013
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Houma, LA (United States)